Temozolomide based treatment in glioblastoma: 6 vs. 12 months
Temozolomide based treatment in glioblastoma: 6 vs. 12 months
About this item
Full title
Author / Creator
Fasano, Morena , Pirozzi, Mario , Falco, Vincenzo De , Miceli, Chiara Carmen , Farese, Stefano , Zotta, Alessia , Famiglietti, Vincenzo , Vitale, Pasquale , Giovanni, Ilaria Di , Brancati, Christian , Carfora, Vincenzo , Solari, Domenico , Somma, Teresa , Cavallo, Luigi Maria , Cappabianca, Paolo , Conson, Manuel , Pacelli, Roberto , Ciardiello, Fortunato and Addeo, Raffaele
Publisher
Athens: Spandidos Publications
Journal title
Language
English
Formats
Publication information
Publisher
Athens: Spandidos Publications
Subjects
More information
Scope and Contents
Contents
The Stupp regimen remains the standard treatment for newly diagnosed glioblastomas, although the prognosis remains poor. Several temozolomide alternative schedules have been studied, with extended adjuvant treatment (>6 cycles of temozolomide) frequently used, although different trials have indicated contrasting results. Survival data of 87 patient...
Alternative Titles
Full title
Temozolomide based treatment in glioblastoma: 6 vs. 12 months
Authors, Artists and Contributors
Author / Creator
Pirozzi, Mario
Falco, Vincenzo De
Miceli, Chiara Carmen
Farese, Stefano
Zotta, Alessia
Famiglietti, Vincenzo
Vitale, Pasquale
Giovanni, Ilaria Di
Brancati, Christian
Carfora, Vincenzo
Solari, Domenico
Somma, Teresa
Cavallo, Luigi Maria
Cappabianca, Paolo
Conson, Manuel
Pacelli, Roberto
Ciardiello, Fortunato
Addeo, Raffaele
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3087860680
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3087860680
Other Identifiers
ISSN
1792-1074
E-ISSN
1792-1082
DOI
10.3892/ol.2024.14551
